Clınıcal and laboratory dıfferences between stentıng and optımal medıcal therapy ın the treatment of coronary artery dısease.
Abstract
The objective was to study the relationship between risk factors and clinical-laboratory indicators in patients receiving treatment for ischemic heart disease with stenting and optimized medical therapy. The study included 70 patients, 37 receiving optimized medical therapy and 33 who had undergone stenting. Biochemical indicators, including cholesterol, triglyceride, and fasting glucose levels, as well as functional indicators such as ejection fraction, were analyzed. No statistically significant differences were found between the groups in terms of biochemical and functional indicators. Both treatment approaches demonstrated similar effectiveness. Stenting remains an important method of treatment, while optimized medical therapy also proves to be effective.
About the Authors
List of references
International Council for Standardization in Haematology (Expert Panel on Blood Rheology), ICSH recommendations for measurement of erythrocyte sedimentation rate, Journal of Clinical Pathology, 1993, March, 46, 03, 198–203, 10.1136/jcp.46.3.198, Erratum in: J Clin Pathol 1993 May;46(5):488. PMID: 8463411; PMCID: PMC501169.
Y. Li, G.Y. Cao, W.Z. Jing, J. Liu, M. Liu, Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990-2019: findings from 2019 global burden of disease study, European Journal of Preventive Cardiology, 2023, 30, 03, 276–286, 10.1093/eurjpc/zwac285.
F.D. Pagani, Commentary: Left ventricular size and left ventricular assist device support outcomes: Bigger is better?, Journal of Thoracic and Cardiovascular Surgery, 2019, June, 157, 06, 2313–2314, 10.1016/j.jtcvs.2019.01.076, 30798961.
W. Qiu, J. Chen, X. Huang, The analysis of the lipid levels in patients with coronary artery disease after percutaneous coronary intervention: a one-year follow-up observational study, Lipids in Health and Disease, 2020, 19, 163, 10.1186/s12944-020-01340-5.
F. Sanchis-Gomar, C. Perez-Quilis, R. Leischik, A. Lucia, Epidemiology of coronary heart disease and acute coronary syndrome, Annals of Translational Medicine, 2016, 4, 013, 256, 10.21037/atm.2016.06.33.
T. Takada, Y. Nakata, K. Matsuura, Y. Minami, M. Kishihara, S. Watanabe, S. Shirotani, T. Abe, A. Yoshida, S. Hasegawa, K. Jujo, K. Arai, A. Suzuki, N. Hagiwara, J. Yamaguchi, Left Ventricular End- Systolic Diameter May Predict Persistent Heart Failure with Reduced Ejection Fraction, International Heart Journal, 2023, November 30, 64, 06, 1095–1104, 10.1536/ihj.23-293, 37967983.
S. Thupakula, S.S.R. Nimmala, H. Ravula, S. Chekuri, R. Padiya, Emerging biomarkers for the detection of cardiovascular diseases, Egyptian Heart Journal, 2022, 74, 01, 77, 10.1186/s43044-022-00317-2.
M. Vaduganathan, G.A. Mensah, J.V. Turco, V. Fuster, G.A. Roth, The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health, Journal of the American College of Cardiology, 2022, 80, 025, 2361–2371, 10.1016/j.jacc.2022.11.005.
William E. Boden, Peter H.Stone, To stent or not to stent? Treating angina after ISCHEMIA—why a conservative approach with optimal medical therapy is the preferred initial management strategy for chronic coronary syndromes: insights from the ISCHEMIA trial, European Heart Journal, 2021, 42, 014, 1394–1400, 10.1093/eurheartj/ehab069.002.
Y.K. Wong, H.F. Tse, Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease, Frontiers in Cardiovascular Medicine, 2021, 8, 713191, 10.3389/fcvm.2021.713191.
Copyright (c) 2024 A.X. Абдусаматов, H.M. Нуриллаева (Автор)
This work is licensed under a Creative Commons Attribution 4.0 International License.